張 維倫

Medicine & Life Sciences

1. Amoxicillin 10%
2. Biomarkers 8%
3. Body Mass Index 11%
4. Carcinogenesis 10%
5. Chemoradiotherapy 33%
6. Clarithromycin 15%
7. Cytochrome P-450 CYP2C19 12%
8. DNA 9%
9. Drug Therapy 8%
10. Duodenal Ulcer 15%
11. Dyspepsia 12%
12. Endoscopy 16%
13. Esomeprazole 35%
14. Esophageal Fistula 12%
15. Esophageal Squamous Cell Carcinoma 99%
16. Esophageal Stenosis 8%
17. Fine Needle Biopsy 11%
18. Gastritis 25%
19. Gastroesophageal Reflux 9%
20. Genotype 12%
21. Helicobacter Infections 19%
22. Helicobacter pylori 100%
23. Hemorrhage 19%
24. Infections 9%
25. Integrins 9%
26. Intensity-Modulated Radiotherapy 16%
27. Levofloxacin 28%
28. Los Angeles 26%
29. Metaplasia 47%
30. Metronidazole 11%
31. Neoplasms 21%
32. Omeprazole 8%
33. Osteopontin 15%
34. Pantoprazole 13%
35. Peptic Esophagitis 40%
36. Peptic Ulcer 26%
37. Proton Pump Inhibitors 8%
38. Pylorus 81%
39. spasmolytic polypeptide 26%
40. Stomach 42%
41. Stomach Neoplasms 41%
42. Stomach Ulcer 17%
43. Survival 18%
44. Therapeutics 16%
45. Trefoil Factor-2 8%
46. Ulcer 10%